Prognostic factors in neuroblastoma

Audrey E. Evans(Purdue University West Lafayette), Hie‐Won Hann(Fox Chase Cancer Center), James A. Anderson(Harvard University), Kathleen J. Propert(Translational Therapeutics (United States)), Giulio J. D’Angio(University of Pennsylvania)

Cancer

June 1, 1987

10.1002/1097-0142(19870601)59:11<1853::aid-cncr2820591102>3.0.co;2-f

Cited by 322

Related Papers

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

|Journal of Clinical Oncology|1993|2.3k

A proposed staging for children with neuroblastoma.Children's cancer study group A

|Cancer|1971|953

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

|The Lancet|2012|739

Treatment of Wilms' tumor. Results of the third national Wilms' tumor study

|Cancer|1989|685

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.

|Journal of Clinical Oncology|1988|608